Brief: ASIT Biotech Says It Is Confident In The Execution Of Its Key Priorities For 2019

European Medical Solutions SA

25/02/2019 06:10

Feb 25 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH IS CONFIDENT IN THE EXECUTION OF ITS KEY
PRIORITIES
FOR 2019
    * GP-ASIT+™ CONFIRMATORY PHASE III STUDY IS ON TRACK TO
DELIVER
PRIMARY RESULTS BY END-2019
    * FIRST INTEREST SHOWN BY POTENTIAL PARTNERS FOR OTHER
ASSETS IN
PRODUCT PIPELINE
    * CASH POSITION OF EUR 8.5M AT END-2018
    * REDUCTION OF PLANNED TOTAL 2019 BUDGET BY EUR 6.0M BY
FOCUSING
ON STRATEGIC PRIORITIES
    * APPROVAL OF A PLANNED PRIVATE PLACEMENT OF CONVERTIBLE
NOTES FOR
A MINIMUM OF EUR 9.0M TO COVER FINANCING REQUIREMENTS UNTIL Q3
OF 2020

Source text for Eikon:  ID:nBw64PYMra 
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))